Martin Kroll, MD
Chief of Laboratory Medicine
Boston Medical Center
Boston Medical Center
Member of the Healthcare Council
Martin Kroll, MD, is the Chief of Laboratory Medicine at the Boston Medical Center and Professor of Pathology at Boston University School of Medicine. Dr. Kroll has expertise in Clinical Chemistry, Hematology, Coagulation, Transfusion Medicine, Microbiology, Laboratory Management and Point-of-Care Testing. He has developed evaluation methods used by the NCCLS (CLSI), such as linearity assessment. His research interests include cardiovascular disease, cancer testing, and renal disease. Dr. Kroll has consulted for the Food and Drug Administration, as well as for Abbott, Biosite, and Roche diagnostic companies. (This is me - Update Profile)
| 1999 - 2008 | Director Core Laboratory VA Medical Center (Dallas) |
|---|---|
| 1993 - 1999 | Associate Director Johns Hopkins Medicine International, L.L.c |
| 1984 - 1993 | Pathologist National Institutes of Health (NIH) |
| Unspecified - present | Chief of Laboratory Medicine Boston Medical Center |
| Unspecified - present | Professor of Pathology Boston University School of Medicine |
GLG Study Groups with Martin Kroll, MD(?)
Martin Kroll, MD is not a member of any GLG Study Groups.
View All Study Groups
View All Study Groups
GLG NewsSM Analyses by Martin Kroll, MD(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Martin Kroll, MD has not published any public GLG News analyses.
View all GLG News in Healthcare
View all GLG News in Healthcare
GLG InstituteSM Seminars with Martin Kroll, MD(?)
Martin Kroll, MD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare
View all GLG InstituteSM Seminars in Healthcare
Request a project with Martin Kroll, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
40 of the leading 50
global mutual funds
global mutual funds
15 of the leading 20
global banks
global banks
8 of the leading 10
private equity firms
private equity firms
90%+ client subscription renewal rate

